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Abstract
Background: Functional gastrointestinal disorders (FGID) may occur following acute
gastroenteritis. This long-term complication has previously not been described after infection with
the non-invasive protozoan Giardia lamblia. This study aims to characterize persistent abdominal
symptoms elicited by Giardia infection according to Rome II criteria and symptoms scores.
Methods: Structured interview and questionnaires 12–30 months after the onset of Giardia
infection, and at least 6 months after Giardia eradication, among 82 patients with persisting
abdominal symptoms elicited by the Giardia infection. All had been evaluated to exclude other
causes.
Results: We found that 66 (80.5%) of the 82 patients had symptoms consistent with irritable
bowel syndrome (IBS) and 17 (24.3%) patients had functional dyspepsia (FD) according to Rome II
criteria. IBS was sub classified into D-IBS (47.0%), A-IBS (45.5%) and C-IBS (7.6%). Bloating,
diarrhoea and abdominal pain were reported to be most severe. Symptoms exacerbation related
to specific foods were reported by 45 (57.7%) patients and to physical or mental stress by 34
(44.7%) patients.
Conclusion: In the presence of an IBS-subtype pattern consistent with post-infectious IBS (PI-IBS),
and in the absence of any other plausible causes, we conclude that acute Giardia infection may elicit
functional gastrointestinal diseases with food and stress related symptoms similar to FGID patients
in general.
Background
Long term abdominal symptoms may develop after acute
gastroenteritis and was first described in 1962 [1]. These
symptoms are clinically similar to functional gastrointes-
tinal diseases (FGID) and may be classified using the
Rome II criteria for such illnesses. Symptoms often fulfil
the criteria for irritable bowel syndrome (IBS) and the
term post-infectious irritable bowel syndrome (PI-IBS) is
often used for this condition [2]. It has been shown to
occur following viral, bacterial and amoebic gastroenteri-
tis and after trichinellosis [1,3,4]. A meta-analysis found
the odds of developing irritable bowel syndrome (IBS) to
be increased sixfold after acute gastroenteritis [5]. Previ-
ously, Giardia infection has been found to trigger abdom-
inal symptoms in patients with established IBS[6], and
Giardia should be ruled out as a possible cause in patients
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functional gastrointestinal diseases elicited by infection
with the non-invasive protozoan Giardia lamblia have not
been described before. Similarly, the relation of patients'
abdominal symptoms and food types and the influence of
physical or mental stress have been well researched
among IBS-patients in general[8,9], but little data exists
regarding such relations in post-infectious FGIDs.
Giardia lamblia is a parasite of the small intestine occur-
ring endemically, or as the cause of waterborne outbreaks.
The parasite is commonly found in children in developing
countries and in travellers to endemic regions. It causes
infections varying from asymptomatic to protracted and
severe illness with diarrhoea, weight loss and malabsorb-
tion[10]. After an outbreak in autumn 2004 of assemblage
B giardiasis in Bergen, Norway, many patients experienced
long-lasting abdominal symptoms despite one or several
courses of metronidazole. They were referred to the local
university hospital for evaluation. Extensive work-up
revealed a surprisingly high rate of duodenal inflamma-
tion both in patients with and without evidence of
chronic infection [11]. All Giardia positive patients were
treated successfully[12]. However, symptoms remained in
many patients despite eradication of the parasite, and they
were followed up regularly.
The main aim of this study was to evaluate the abdominal
symptoms according to the Rome II criteria for FGID
among patients with persisting abdominal symptoms 12–
30 months after the onset of Giardia infection, and more
than 6 months after Giardia eradication. Secondarily, we
included some questions about the symptoms relation to
food types and stress.
Methods
This is a prospective study describing the results of ques-
tionnaires and structured interviews during follow-up vis-
its of patients with persisting symptoms following Giardia
infection. The data were collected during a 16 month
period from January 2006 until April 2007.
All 82 patients included in this study had laboratory con-
firmed giardiasis during an outbreak in 2004. They had
been successfully treated and were confirmed Giardia neg-
ative by microscopy of three or more faecal samples at
least 6 months prior to inclusion in this study. An exten-
sive work-up including upper endoscopy with duodenal
biopsies, routine blood screening tests, immunoglobu-
lins, IgE, serum anti-endomysial, anti-tissue transglutam-
inase antibodies and faecal calprotectin had not produced
any findings to explain their symptoms [11]. In 11
patients included in this study, repeated routine duodenal
biopsies were taken approximately one year after the ini-
tial work-up, and these were reviewed with regard to
inflammatory changes.
After the initial extensive work-up, patients came for fol-
low up visits where, in addition to routine clinical exami-
nation, a structured interview was performed with regard
to previous abdominal symptoms, and symptom exacer-
bation related to food types or physical or mental stress.
In the interview most patients denied previous abdominal
illness, while 14 (17.1%) had experienced some previous
abdominal symptoms. All these 14 patients reported con-
siderable more abdominal problems after Giardia infec-
tion than they had had before. Only 5 of them reported
previous contact with a physician about their abdominal
problems. For clarity we chose to give results for patients
without previous abdominal complaints separately in the
analysis.
Patients also filled in a questionnaire regarding their cur-
rent abdominal symptoms allowing evaluation of IBS
according to the Rome II criteria[13]. As it became evident
that functional dyspepsia (FD) was occurring in our
patient population, Rome II FD criteria questions were
included in the questionnaires. IBS patients were sub clas-
sified into diarrhoea-predominant IBS (D-IBS: two or
more diarrhoea symptoms and a maximum of one symp-
tom of constipation), constipation-predominant IBS (C-
IBS: two or more constipation symptoms and a maximum
of one symptom of diarrhoea) and alternating IBS (A-IBS:
all subjects with IBS not qualifying for D-IBS or C-IBS).
Symptom severity, for the last month, of nausea, bloating,
abdominal pain, diarrhoea, constipation and anorexia
was quantified by patients grading these symptoms on an
ordinal scale from 0 – 10 with 0 = no symptoms and 10 =
severe symptoms.
Statistical analysis was performed using SPSS 16.0. The
Regional ethics committee and the Norwegian Social Sci-
ence Data Services approved the data collection and anal-
ysis of the data.
Results
There were 52 females (63.4%) and the mean age was
31.8 years (range 18–61). Analysis of the collected data
showed a high frequency of patient's symptoms fulfilling
the Rome II IBS criteria with D-IBS and A-IBS of similar
prevalence (Table 1). IBS-C was uncommon. Regarding
FD, 17 cases were identified and 10 of these also had con-
current IBS. The 6 cases fulfilling neither FD nor IBS crite-
ria could be put into one or more of the Rome II
categories; functional abdominal pain, functional diar-
rhoea and functional bloating.
No significant sex differences were found regarding IBS
subtypes, symptom scores, influence of stress or subjective
food intolerance, only trends towards more FD among
females (p = 0.09) and more females reporting previous
abdominal symptoms (p = 0.07). Patients with FD had
similar symptom scores as non-FD patients except for thePage 2 of 5
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in non-FD patients with a p-value < 0.001.
Bloating was the symptom reported to be most severe
(Table 2). In fact only two patients reported nil bloating.
Symptoms of diarrhoea and constipation varied consist-
ently with IBS subtype. No gender differences were found,
only a trend towards nausea being more severe among
females (p = 0.08).
The question of food related worsening of symptoms was
answered by 78 patients. The majority of patients (57.7%)
reported their post-giardiasis abdominal problems to
worsen after intake of certain food items. They were asked
to name the food items they had begun to avoid. Milk and
milk products were mentioned spontaneously by 27% of
the patients. Other common food items mentioned were
alcohol containing beverages (18.4%), wheat flour prod-
ucts (14.5%) and coffee (6%).
In 76 patients who responded to the question about the
influence of physical or mental stress on their abdominal
symptoms, 44.7% felt that their abdominal illness was
worsened by stress. No correlations were found between
IBS-subtypes and symptoms exacerbation related to stress
and food types.
Signs of inflammation with infiltration of inflammatory
cells, with or without shortening and blunting of intesti-
nal villi, were found in 8 out of 11 of these patients during
the first workup in spring 2005. One year later, repeated
routine duodenal biopsies were normal in ten and
improved in one of these patients, although all these
patients still had troubling abdominal symptoms (data
not shown).
Discussion
Clinical characteristics of a relatively large number of
patients seeking help for long lasting abdominal symp-
toms after Giardia infection are described in this study. An
extensive follow-up of these patients over three years has
not revealed any specific illness, which can explain the
symptoms seen in our study population. The prolonged
symptoms in parasitologically successfully treated
patients came as a surprise, as such complications have
not been described after Giardia infection before.
Table 1: Frequency of FGID and relation of abdominal symptoms to food types and stress
Patients without previous abdominal symptoms 
N = 68
All patients
N = 82
N % N %
IBS all subtypes 54 79.4 66 80.5
D – IBS1 25 46.3 31 47.0
A – IBS1 27 50.0 30 45.5
C – IBS1 3 5.6 5 7.6
FD2 14 21.9 17 24.3
IBS & FD2 8 12.5 10 14.3
Other FGID (not IBS/FD) 6 8.8 6 7.3
Food related symptoms3 37 56.1 45 57.7
Stress related symptoms4 26 40.6 34 44.7
1 Percentages within subgroup with IBS
2 70 patients with available FD data
3 78 patients with available food related data
4 76 patients with available stress related data
Table 2: Symptom scores in IBS subtypes and in the group with other FGIDs.
Symptom D-IBS
N = 31
A-IBS
N = 30
C-IBS
N = 5
Other FGID
N = 16
All
N = 82
Nausea 2.8 ± 0.4 3.1 ± 0.5 3.4 ± 1.5 3.0 ± 0.8 3.0 ± 0.3
Bloating 6.2 ± 0.4 7.0 ± 0.4 8.0 ± 0.8 5.4 ± 0.8 6.4 ± 0.2
Abd.pain 3.9 ± 0.5 4.6 ± 0.4 5.2 ± 1.0 3.8 ± 0.6 4.2 ± 0.3
Constipation 1.7 ± 0.5 3.1 ± 0.5 3.8 ± 1.2 0.9 ± 0.3 2.2 ± 0.3
Diarrhea 5.4 ± 0.4 4.5 ± 0.5 3.4 ± 1.0 4.3 ± 0.7 4.8 ± 0.3
Anorexia 2.0 ± 0.5 1.5 ± 0.4 2.4 ± 0.8 1.1 ± 0.5 1.7 ± 0.3
Total score 22.1 ± 1.5 23.9 ± 1.6 26.2 ± 5.0 19.1 ± 2.1 22.3 ± 1.0
Values given are mean scores ± standard error.Page 3 of 5
(page number not for citation purposes)
BMC Gastroenterology 2009, 9:27 http://www.biomedcentral.com/1471-230X/9/27There have been several Giardia outbreaks described,
among others in Solna, Sweden[14], Creston, Canada
[15] and Aspen highlands, USA[16]. However, no follow-
up studies have looked at persistent symptoms after erad-
ication of the parasite. An epidemiological study in Mich-
igan, USA[17] did not find any link between Giardia
infection and IBS, by correlating new Giardia cases with
prescriptions of three drugs (dicyclomine, tegaserod and
alosetron) used in IBS. In our study population any such
correlation would probably also not have been found as
patients were previously largely healthy, active young peo-
ple unaccustomed to taking drugs daily. Only a few had
abdominal complaints of a severity that any of these med-
ications would be considered.
In our study population we find a pattern of IBS-subtypes
with a high frequency of diarrhoeal symptoms and little
constipation. This agrees well with previous descriptions
of PI-IBS as a distinctive subgroup of IBS patients [18]. In
the general population in Norway a recent study with
4622 respondents showed that 10% in the relevant age
group fulfilled the IBS criteria and the pattern of subtypes
contrasts our findings with subtype A-IBS most com-
monly reported (53%), followed by similar prevalence of
the other two subtypes D-IBS (23%) and C-IBS (24%)
[19].
It is known that Giardia may cause prolonged symptoms
for several weeks after successful treatment due to second-
ary lactose intolerance [20]. In the present study we found
that many patients reported many different kinds of food
to worsen symptoms and that this persisted for years after
infection. A previous study has not found lactose-intoler-
ance to be factor in the aetiology of PI-IBS after bacterial
gastroenteritis[21]. Preliminary data from duodenal
lactase activity testing in newly referred patients with post-
giardiasis IBS at our hospital support this finding (unpub-
lished).
It is known that food-related gastrointestinal symptoms
are common in the general population and often coin-
cides with IBS. A previous study found that 51% of IBS-
patient considered that their symptoms were linked to
individual foods [8], and improvement following exclu-
sion diets have also been reported [22]. However, objec-
tive measurements methods, like skin prick test or
intestinal permeability have not been consistent with the
reported food-intolerance [23]. Outside of this study
many of the patients were referred to allergologic evalua-
tion with no specific findings. It thus seems that the food-
related symptoms seen in our patient population may be
intrinsically linked with the development of FGID.
The finding that around half the patients felt that physical
or mental stress influence their abdominal symptoms is
consistent with previous findings in patients with IBS of
all causes seeking medical care in Norway [9].
It remains speculative what may be the reason for devel-
opment of FGID after Giardia infection. Previous studies
have pointed to psychological factors, young age, and
severity and duration of the acute infection as factors
increasing the risk of FGID after bacterial gastroenteritis
[2,5]. We showed in a former study that a high frequency
of microscopic duodenal inflammation was found in our
study population when illness duration was 2–4 months,
indicating that the severity of host response may be a risk
factor for FGID in our population [11]. The initially high
frequency of duodenal microscopic inflammation nor-
malised within a year, but subtle low-grade inflammation,
not recognised by routine microscopy might be ongoing.
The particular genotype of Giardia responsible for the epi-
demic may also be a relevant risk factor in itself, as differ-
ent strains have been shown to differ in their ability to
induce small intestinal injury in rats [24]. The higher pro-
portion of females in our study population is probably
not indicating an increased risk, but rather a reflection of
more females contracting giardiasis during the epidemic,
probably as a consequence of higher water intake [25].
Host factors like age, no previous Giardia exposure or
infection, pre-existing intestinal microbiota, immuno-
logic and genetic predisposition may also play a role.
These will be interesting issues for further research.
All patients were treated with one or more courses of met-
ronidazole for their giardiasis. Although one study points
to a link between antibiotic treatment in general and
FGID[26], prolonged gastrointestinal symptoms is not
reported as a side effect of metronidazole. Although we
can not fully exclude this possibility, we think the Giardia
infection is a far more plausible cause of the later FGID
than its treatment.
A strength of this study is the relatively large number of
laboratory confirmed giardiasis cases who have been thor-
oughly investigated and followed for a long period of
time. However, it is therefore also important to note that
our data are drawn from a population likely to be the
more severely affected, and may not represent patients
with milder post-giardiasis abdominal symptoms. A con-
trol group presented with the same follow-up and ques-
tionnaire would have been desirable.
Patients were asked about previous abdominal com-
plaints retrospectively, one to two years after their Giardia
infection. Recall bias might influence the answers given.
Some caution should also be taken regarding the exclu-
sion of chronic giardiasis. Microscopy of three stool sam-
ples for Giardia cysts has a sensitivity of 85 – 90%[27].Page 4 of 5
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ative faecal samples before referral and during the hospi-
tal workup, thus we consider the risk of low-grade chronic
infections to be very small.
Conclusion
Due to the subtype pattern consistent with PI-IBS, no
other discernable cause, and symptoms being elicited by a
symptomatic, laboratory confirmed Giardia infection, we
here document for the first time that the non-invasive pro-
tozoan pathogen Giardia lamblia may induce irritable
bowel syndrome and functional dyspepsia. Utilising the
unique setting of around 1300 laboratory confirmed Gia-
rdia cases, we are planning follow up studies of the fre-
quency and characteristics of FGID after Giardia infection
including population based approaches.
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